FoxOs function synergistically to promote glucose production

Area of Science:

• Metabolic regulation
• Molecular endocrinology
• Gene transcription

Background:

• Hepatic glucose production (HGP) is crucial for maintaining blood glucose homeostasis.
• Transcription factor FoxO1 regulates HGP and its response to hormones.
• Liver-specific FoxO1 deletion (L-FoxO1) reduces HGP and glucose production gene expression.

Purpose of the Study:

• To investigate the roles of additional transcription factors, specifically FoxO3, FoxO4, and FoxA2, in regulating HGP.
• To determine the collective contribution of FoxO family members to hepatic glucose metabolism.

Main Methods:

• Creation of liver-specific double and triple knockout mouse models.
• Analysis of mouse models with deletions in FoxO1, FoxO3, FoxO4, and FoxA2.
• Assessment of metabolic parameters including fasting hypoglycemia, glucose tolerance, insulin sensitivity, and plasma insulin levels.

Main Results:

• Triple ablation of FoxO genes (FoxO1, FoxO3, FoxO4) resulted in more severe fasting hypoglycemia compared to single FoxO1 knockout.
• Triple FoxO knockout mice exhibited increased glucose tolerance and enhanced insulin sensitivity.
• Combined ablation of FoxO1 and FoxA2 did not produce a more pronounced phenotype than FoxO1 single knockout.
• Plasma insulin levels were decreased in triple FoxO knockout mice.

Conclusions:

• The FoxO family of transcription factors (FoxO1, FoxO3, FoxO4) functions synergistically to regulate hepatic glucose metabolism.
• FoxO transcription factors play a critical, cooperative role in controlling glucose production and insulin sensitivity.
• FoxA2 does not appear to play a redundant role with FoxO1 in this context.